A subset of cell clusters with malignant features in morphologically normal-appearing and hyperplastic tissues

Beckmann, 1997, Multistep carcinogenesis of breast cancer and tumour heterogeneity, J Mol Med, 75, 429, 10.1007/s001090050128 Boyd, 1990, Genetic and cellular basis of multistep carcinogenesis, Pharmacol Ther, 46, 469, 10.1016/0163-7258(90)90028-Z Schedin, 2004, Multistep tumorigenesis and the microenvironment, Breast Cancer Res, 6, 93, 10.1186/bcr772 Pitot, 1993, Multistage carcinogenesis—genetic and epigenetic mechanisms in relation to cancer prevention, Cancer Detect Prev, 17, 567 Page, 1998, Premalignant and malignant disease of the breast: the roles of the pathologist, Mod Pathol, 11, 120 Singletary, 2003, Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual, Surg Clin North Am, 83, 803, 10.1016/S0039-6109(03)00034-3 Lakhani, 2000, The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2, Clin Cancer Res, 6, 782 Jensen, 2003, Ductal carcinoma in situ of the breast: impact of pathology on therapeutic decisions, Am J Surg Pathol, 27, 828, 10.1097/00000478-200306000-00015 Hadjisavvas, 2002, Correlation between morphology, immunohistochemistry and molecular pathology in hereditary and sporadic breast cancer cases, Ultrastruct Pathol, 26, 237, 10.1080/01913120290104494 Azzopardi, 1979 Moinfar, 2000, Genetic abnormalities in mammary ductal intraepithelial neoplasis-flat-type (“clinging ductal carcinoma in situ”). A simulator of normal mammary epithelium, Cancer, 88, 2072, 10.1002/(SICI)1097-0142(20000501)88:9<2072::AID-CNCR13>3.0.CO;2-H Nieburgs, 2004, Cell morphology in the field effects and in sites distant from malignant tumors, Cancer Detect Prev, 28, S181 Nieburgs, 1965, Cellular changes in liver tissue adjacent and distant to malignant tumors, Arch Pathol, 80, 262 Nieburgs, 1963, Interpretation of cellular changes preceding invasive uterine cervix carcinoma, Cancer, 16, 480, 10.1002/1097-0142(196304)16:4<480::AID-CNCR2820160409>3.0.CO;2-Y Nieburgs, 1962, Buccal cell changes in patients with malignant tumors, Lab Invest, 11, 80 Bartek, 1990, Patterns of expression of the p53 tumor suppressor in human breast tissues and tumours in situ and in vitro, Int J Cancer, 46, 839, 10.1002/ijc.2910460515 Moll, 1992, Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion, Proc Natl Acad Sci USA, 89, 7262, 10.1073/pnas.89.15.7262 Man, 2005, Expression of BP1, a novel homeotic gene, correlates with breast cancer progression and invasion, Breast Cancer Res Treat, 90, 241, 10.1007/s10549-004-4492-9 Slamon, 1989, Studies of the Her-2/new proto-oncogene in human breast and ovarian cancer, Science, 244, 707, 10.1126/science.2470152 Man, 2003, Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion, Breast Cancer Res, 5, R231, 10.1186/bcr653 Man, 2004, The significance of focal myoepithelial cell layer disruptions in human breast tumor invasion: a paradigm shift from the “protease-centered” hypothesis, Exp Cell Res, 301, 103, 10.1016/j.yexcr.2004.08.037 Man, 2005, cDNA expression profiling identifies elevated expressions of tumor progression and invasion related genes in cell clusters of in situ breast tumors, Breast Cancer Res Treat, 89, 199, 10.1007/s10549-004-2049-6 Niederacher, 1996, Detection of sequential genetic alterations relevant for breast cancer development, Eur J Cancer, 5, 497 Barrett, 1993, Mechanism of multistep carcinogenesis and carcinogen risk assessment, Environ Health Perspect, 100, 9, 10.1289/ehp.931009 Mayer, 2005, Genetic disposition to addictive disorders—current knowledge and future perspectives, Curr Opin Pharmacol, 5, 4, 10.1016/j.coph.2004.08.009 Nowell, 1976, The clonal evolution of tumor cell populations, Science, 94, 23, 10.1126/science.959840 Tavassoli, 1995, Morphofunctional features of intraductal hyperplasia, atypical hyperplasia, and various grades of intraductal carcinoma, Breast J, 1, 155, 10.1111/j.1524-4741.1995.tb00233.x Man, 2003, An antigen unmasking protocol that satisfies both immunohistochemical and subsequent molecular biological assessments, Pathol Res Pract, 199, 815, 10.1078/0344-0338-00501 Man, 1996, A simple epitope retrieval method without the use of microwave oven or enzyme digestion, Appl Immunohistochem, 4, 139 Handschuh, 1999, Tumor-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility, Oncogene, 8, 4301, 10.1038/sj.onc.1202790 Luber, 2000, Tumor-derived mutated E-cadherin influences beta-catenin localization and increases susceptibility to actin cytoskeletal changes induced by pervanadate, Cell Adhes Commun, 7, 391, 10.3109/15419060009109021 Fricke, 2003, Relationship between E-cagherin gene mutation and p53 gene mutation, p53 accumulation. Bcl-2 expression and Ki-67 staining in diffuse-type gastric carcinoma, Int J Cancer, 104, 60, 10.1002/ijc.10879 Moll, 2004, p63 and p73: roles in development and tumor formation, Mol Cancer Res, 2, 371, 10.1158/1541-7786.371.2.7 Harms, 2004, The common and distinct target genes of the p53 family transcription factors, Cell Mol Life Sci, 61, 822, 10.1007/s00018-003-3304-4 Alam, 2004, Differential expression of CD44 during human prostate epithelial cell differentiation, J Histochem Cytochem, 52, 1083, 10.1369/jhc.4A6256.2004 Schmidt, 2004, CD44 variant isoforms associate with tetraspanins and EpCAM, Exp Cell Res, 297, 329, 10.1016/j.yexcr.2004.02.023 Sowter, 2005, BRCA1 and BRCA2 as ovarian cancer susceptibility genes, Carcinogenesis, 26, 1651, 10.1093/carcin/bgi136 Zhang, 2000, Maspin is an angiogenesis inhibitor, Nature Med, 6, 96, 10.1038/71600 Barbareschi, 2001, p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast, Am J Surg Pathol, 25, 1954, 10.1097/00000478-200108000-00010 Yousefi, 2005, Mammary ducts with and without focal myoepithelial cell layer disruptions show a different frequency of white blood cell infiltration and growth pattern: implications for tumor progression and invasion, Appl Immunohistochem Mol Morphol, 13, 30, 10.1097/00129039-200503000-00006 Man, 2005, Focal prostate basal cell layer disruptions and leukocyte infiltration are correlated events: a potential mechanism for basal cell layer disruptions and tumor invasion, Cancer Detect Prev, 29, 161, 10.1016/j.cdp.2005.01.004 Gehlsen, 1988, Inhibition of in vitro tumor cell invasion by Arg-Gly-Asp-containing synthetic peptides, J Cell Biol, 106, 925, 10.1083/jcb.106.3.925 Marshall, 1996, The role of alpha v-integrins in tumor progression and metastasis, Semin Cancer Biol, 7, 129, 10.1006/scbi.1996.0018 Anker, 2000, Circulating DNA in plasma or serum, Medicina (B Aires), 60, 699 Anker, 2001, Circulating nucleic acids in plasma or serum, Clin Chim Acta, 313, 143, 10.1016/S0009-8981(01)00666-0 Anker, 2001, Tumor-related alterations in circulating DNA, potential for diagnosis, prognosis and detection of minimal residual disease, Leukemia, 15, 289, 10.1038/sj.leu.2402016 Anker, 2003, Circulating nucleic acidis in plasma amd serum as a noninvasive investigation for cancer: time for large-scale clinical studies?, Int J Cancer, 103, 149, 10.1002/ijc.10791 Garcia-Olmo, 2004, Circulating nucleic acidis in plasma and serum (CNAPS) and its relation to stem cells and cancer metastasis: state of the issue, Histol Histopathol, 19, 575 Garcia-Olmo, 2001, Functionality of circulating DNA: the hypothesis of genometastasis, Ann NY Acad Sci, 945, 265, 10.1111/j.1749-6632.2001.tb03895.x Anker, 1999, Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients, Cancer Metastasis Rev, 18, 65, 10.1023/A:1006260319913